Robin Hayeems
Biographic Data
| ID | 5514090 |
|---|---|
| NAME | Robin Hayeems |
| GIVEN NAMES | Robin |
| FAMILY NAME | Hayeems |
| SIGNATURE | HAYEEMS R |
| AFFILIATIONS | Child Health Evaluative Studies, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada |
| VERIFIED | No |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 6 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Family‐centred care interventions for children with chronic conditions
Access to novel drugs and therapeutics for children and youth
INTRODUCTION: The unique evidentiary, economic and ethical challenges associated with health technology assessment (HTA) of precision therapies limit access to novel drugs and therapeutics for children and youth, for whom such challenges are amplified. We elicited citizens' perspectives about values-based criteria relevant to the assessment of paediatric precision therapies to inform the development of a child-tailored HTA framework. METHODS: We …
Determining accurate costs for genomic sequencing technologies—a necessary prerequisite
Genetic Testing among Children in a Complex Care Program
Little is known about the pattern of genetic testing and frequency of genetic diagnoses among children enrolled in structured complex care programs (CCPs). Such information may inform the suitability of emerging genome diagnostics for this population. The objectives were to describe the proportion of children with undiagnosed genetic conditions despite genetic testing and measure the testing period, types and costs of genetic tests used. A retros…
Does personal genome testing drive service utilization in an adult preventive medicine clinic
Governing population screening in an age of expansion
No prominent works on this page.
Governing population screening in an age of expansion
Genetic Testing among Children in a Complex Care Program
Little is known about the pattern of genetic testing and frequency of genetic diagnoses among children enrolled in structured complex care programs (CCPs). Such information may inform the suitability of emerging genome diagnostics for this population. The objectives were to describe the proportion of children with undiagnosed genetic conditions despite genetic testing and measure the testing period, types and costs of genetic tests used. A retros…
Does personal genome testing drive service utilization in an adult preventive medicine clinic
Determining accurate costs for genomic sequencing technologies—a necessary prerequisite
Access to novel drugs and therapeutics for children and youth
INTRODUCTION: The unique evidentiary, economic and ethical challenges associated with health technology assessment (HTA) of precision therapies limit access to novel drugs and therapeutics for children and youth, for whom such challenges are amplified. We elicited citizens' perspectives about values-based criteria relevant to the assessment of paediatric precision therapies to inform the development of a child-tailored HTA framework. METHODS: We …
Family‐centred care interventions for children with chronic conditions
Medicine (5 works) · Computer Science (3 works) · Health Systems, Economic Evaluations, Quality of Life (3 works) · Nursing (3 works) · Psychology (3 works) · Public health (3 works) · Biology (2 works) · BRCA gene mutations in cancer (2 works) · Business (2 works) · Corporate governance (2 works)